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Introduction
The high-fat, low-carbohydrate KD is a well-known add-
on treatment option for children with medically intract-
able epilepsy. Anticonvulsants as topiramate can be helpful
for migraine prophylaxis in chilndren, however, there are
severe cautions by using chronic drug treatment by the
parents. Several mechanics may exist for the effect of KD
in CNS diseases: including disruption of glutamatergic
synaptic transmission, inhibition of glycosis, activation of
ATP-sensitive potassium channels and alteration of the
mTOR pathway by modifying the brain excitability.
Aims
The objective of our study was to evaluate the efficacy
and tolerability of Ketogenic Diet (KD) in the prophylac-
tic treatment of migraine in adolescents.
Patient and methods
We have selected adolescents patients between the age of
12-17 years over a 3 month period beginning January
2013. The subjects had a minimum of two attacks per
month before applying the ketogenic diet, for at least 1
year. Migraine was diagnosed by IHS-R criteria. A total of
16 children were recruited including 10 females and 6
males. Migraine attack frequency prior to diet and 1, 2
and 3 months after the initiation of KD were compared
and the clinical effect of the diet was evaluated. The effi-
cacy was evaluated as completely headache free, markedly
effective (attack reduction > 75%), effective (reduction >
50%) or invalid (reduction < 50%). The ratio of fat to car-
bohydrate plus protein was 3:1. Urine ketones were
checked randomly at least twice a week. The KD was
started in outpatient care without using a fasting period.
The diet was planned for a minimum period of 3 months
with the assistance of dieticians.
Results
Of the total 16 patients 7 discontinued the restrictive diet
because of poor compliance (5) and gastrointestinal side
effects (2). 9 patients (100%) continued the study for more
than 1 month. From those 3 patients were interpreted as
invalid responder and discontinued the diet because of
lack of efficacy prior to the 2 months visit. 6 subjects
(77%) completed the 3 months study period. At the end of
the study no subject became completely attack free. The
diet was markedly effective for 3 patients (33%) and effec-
tive for 3 patients (33%). During the 3 months period an
obvious upper trend in the efficacy was observed.
Conclusions
The compliance of adolescents migraineurs with a
restrictive type of KD is problematic, however at the
beginning all of the subjects were absolutely open for a
non-pharmacological “natural” treatment. Furtheron,
most of the patients were additionally motivated to use
the KD by its potential weight loss effect, however, all of
subjects had clinically normal weight at baseline. An
obvious improvement in the headache frequency was
observed in about 77% of the patients who were able to
continue the restrictive diet for at least a 3 months per-
iod. The increase of the efficacy correlated with the
duration of therapy.
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